other material
confidence high
sentiment positive
materiality 0.55
Recursion partners with Enamine to create enriched screening libraries using MatchMaker predictions on 36B compounds
RECURSION PHARMACEUTICALS, INC.
- Up to 100 biological targets selected; Recursion's MatchMaker predicts protein-ligand interactions across Enamine's 36B REAL Space compounds.
- Recursion will receive significant number of unique REAL compounds at no cost and preferential pricing on enriched libraries.
- Enamine may offer resulting libraries to customers; libraries co-branded under Enamine and MatchMaker trademarks.
- MatchMaker uses ML for binding predictions, more scalable than traditional docking; expedites wet-lab experiments.